Shanghai MicroPort EP MedTech Past Earnings Performance
Past criteria checks 4/6
Shanghai MicroPort EP MedTech has been growing earnings at an average annual rate of 71.4%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 23.4% per year. Shanghai MicroPort EP MedTech's return on equity is 2.1%, and it has net margins of 9.3%.
Key information
71.4%
Earnings growth rate
71.6%
EPS growth rate
Medical Equipment Industry Growth | 16.0% |
Revenue growth rate | 23.4% |
Return on equity | 2.1% |
Net Margin | 9.3% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
There May Be Underlying Issues With The Quality Of Shanghai MicroPort EP MedTech's (SHSE:688351) Earnings
Nov 02Shanghai MicroPort EP MedTech's (SHSE:688351) Performance Raises Some Questions
May 02Recent updates
There May Be Underlying Issues With The Quality Of Shanghai MicroPort EP MedTech's (SHSE:688351) Earnings
Nov 02Shanghai MicroPort EP MedTech Co., Ltd.'s (SHSE:688351) Share Price Matching Investor Opinion
Oct 23Calculating The Fair Value Of Shanghai MicroPort EP MedTech Co., Ltd. (SHSE:688351)
Aug 20Shanghai MicroPort EP MedTech's (SHSE:688351) Performance Raises Some Questions
May 02Shanghai MicroPort EP MedTech Co., Ltd.'s (SHSE:688351) 25% Jump Shows Its Popularity With Investors
Mar 02Revenue & Expenses Breakdown
How Shanghai MicroPort EP MedTech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 384 | 36 | 157 | 84 |
30 Jun 24 | 385 | 21 | 160 | 89 |
31 Mar 24 | 366 | 19 | 160 | 88 |
31 Dec 23 | 329 | 6 | 152 | 91 |
30 Sep 23 | 304 | 12 | 139 | 88 |
30 Jun 23 | 281 | 4 | 132 | 84 |
31 Mar 23 | 257 | -6 | 122 | 84 |
31 Dec 22 | 260 | 3 | 118 | 77 |
30 Sep 22 | 245 | -4 | 117 | 74 |
30 Jun 22 | 221 | -7 | 107 | 70 |
31 Mar 22 | 200 | -10 | 103 | 66 |
31 Dec 21 | 190 | -12 | 105 | 63 |
31 Dec 20 | 141 | 6 | 71 | 40 |
31 Dec 19 | 117 | -15 | 64 | 40 |
31 Dec 18 | 84 | -2 | 37 | 24 |
30 Jun 18 | 77 | -5 | 56 | 1 |
31 Mar 18 | 70 | -10 | 56 | 0 |
31 Dec 17 | 62 | -14 | 55 | 0 |
30 Sep 17 | 57 | -17 | 43 | 12 |
30 Jun 17 | 53 | -19 | 43 | 12 |
31 Mar 17 | 49 | -19 | 46 | 6 |
31 Dec 16 | 46 | -19 | 50 | 0 |
31 Dec 15 | 37 | -17 | 40 | 0 |
Quality Earnings: 688351 has a large one-off gain of CN¥51.9M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 688351's current net profit margins (9.3%) are higher than last year (3.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688351 has become profitable over the past 5 years, growing earnings by 71.4% per year.
Accelerating Growth: 688351's earnings growth over the past year (202.1%) exceeds its 5-year average (71.4% per year).
Earnings vs Industry: 688351 earnings growth over the past year (202.1%) exceeded the Medical Equipment industry -8.8%.
Return on Equity
High ROE: 688351's Return on Equity (2.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 17:52 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai MicroPort EP MedTech Co., Ltd. is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Bo Yu | China International Capital Corporation Limited |
Yuan Gao | China International Capital Corporation Limited |
Shuo Song | Citic Securities Co., Ltd. |